ODDB.org: Open Drug Database

Mepha Pharma AG - Montelukast-Mepha 4 mg, Kautabletten

Swissmedic Registration	62361	Sequence	01
Product name	Montelukast-Mepha 4 mg	Description	Kautabletten
ATC-Classification	R03DC03	ATC-Description	Montelukast
Introduction of Sequence	19.12.2012

Composition

montelukastum 4 mg ut montelukastum natricum, mannitolum, natrii laurilsulfas, hydroxypropylcellulosum, carboxymethylamylum natricum A, magnesii stearas, aromatica (Kirsche) cum eugenolum et citralum et limonenum, aspartamum 0.5 mg, E 172 (rubrum), pro compresso corresp. natrium 0.81 mg.

Packungsbestandteile

Galenic Form

Chewing tablets

Active Agent	Dose
Montelukast	4 mg

BAG: Active Agent	Dose
Montelukast	4 mg

Inactive agents	Dose	additional_information
(Rubrum)
Aromatica (Kirsche) cum Eugenolum
Aspartame	0.5 mg
Carboxymethylamylum Natricum A
Citral
E 172		color.
Hydroxypropylcellulosum
Limonenum
Magnesii Stearas
Mannitol
Natrii Laurilsulfas
Pro Compresso

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	28 Tablet(s)	16.79	34.70	B	SL	Yes
002	98 Tablet(s)	58.62	80.15	B	SL	Yes

2025	©ywesee GmbH